Hung-Chang Chen

Hung-Chang Chen is a Senior Scientist at AstraZeneca with over 10 years of extensive research experience in cancer immunology, specializing in innate and adaptive immune systems. Prior to their current role, they held positions at Trinity College Cambridge and the University of Cambridge, where they contributed significantly to various research projects and supervised numerous students in the field. Hung-Chang obtained a Ph.D. in Immunology from Cardiff University and holds both a Master’s and Bachelor’s degree in Biomedical Sciences from Chang Gung University. Their work involves the development of innovative therapeutic strategies and the characterization of immune cell landscapes in cancer research.